Congenital nephrotic syndrome of Finnish type (CNF) is a distinct disease entity characterized at birth by a large placenta and subsequently by early onset of symptoms, complete resistance to steroids, and death, usually within the first 2 years of life (Hailman, Norio, and Rapola, 1973; Norio, 1974) .
The disease is inherited as an autosomal recessive trait, and is exceptionally common in Finland, where the incidence has been estimated to be about 1 in 10 000 births (Norio, 1966) . The purpose of this investigation was to determine the frequency of the principal clinical signs in CNF, the cause of death, and the precise incidence of this disease in Finland.
Patients and methods All known patients with CNF born in Finland from the beginning of 1965 to the end of 1973, were included in the study. Since this disease was first defined (Hallman, Hjelt, and Ahvenainen, 1956 ), a list of the new cases of CNF occurring in Finland has been maintained at the Children's Hospital, University of Helsinki. Some patients were included retrospectively when a second child with CNF was born into a family. Most subjects were assembled from the above list, but some were identified from a review of death certificates at the Central Statistical Office of Finland for the years 1965-1973. Diagnosis of CNF was based on a large placenta, Received 28 July 1975. massive proteinuria, early onset of oedema, asnd a typical course of the disease. In 89% of the patients studied histological examination of renal tissue obtained by biopsy or at necropsy confirmed the diagnosis (Rapola and Savilahti, 1971) . The data presented here are based on hospital and necropsy records. Urine analyses and determinations of blood urea nitrogen or serum creatine levels were performed by standard methods.
The Finland, 1976) . Based on these figures the incidence of CNF in Finland is 12 *2/105, or nearly 1 in 8200 births. Fig. 1 gives the gestational ages of CNF patients and control subjects, and Fig. 2 the birthweights and body lengths. Every newborn whose gestational age ranged from 33-37 weeks, every 5th newborn whose gestational age was 38 weeks, and every 10th newborn whose gestational age was 39 or 40 weeks were included in the group of controls presented in Fig. 2 Proteinuria occurred in all but one patient from the time of the first urine sample (Table II) . The time of onset of oedema or abdominal distension was noted in 61 CNF patients (Table II) , either or both occurring during the first week of life in 32, during the first month in 55, and in none later than 2 months of age. The exact time of and reason for the first admission to a paediatric ward was known in 69 cases (Table III) . (1) Information about the blood urea nitrogen (BUN) or serum creatinine levels was available for 50 CNF patients. Slightly raised levels of BUN occurred in 8 patients (range 23 -57 mg/100 ml) and of serum creatinine in 6 (range 0*8-3 * 0 mg/100 ml). In none, however, was a uraemic syndrome documented.
All CNF patients died during the observation period. Length of survival is shown in Fig. 3 . Mean survival for the 75 patients was 7 *6 months. The oldest patient was aged 2 years 2 months 10 days at death. At necropsy, thrombosis of the inferior vena cava was found in 7 cases, of sagittal sinus in 1, of cerebral vein in 1, and of right atrium in 1. In addition, 1 patient died of a pulmonary embolism that had originated from the right atrium. Severe thromboembolic complications were found in a total of 11 out of 58 necropsies. Cause of death of CNF patients is shown in Table IV . Infection was considered to be the cause of death in 23 cases, renal transplantation in 9, thrombotic complications in 4, and other definable causes in 7. Death could be attributed to no definable cause other than CNF in 32 cases.
Discussion
Taking into account all previously published cases (Norio, 1966; Hallman, Norio, and Kouvalainen, 1967) plus the cases in the present study in which the period of investigation extended through 1973, a total of 151 CNF patients from 119 families have been identified in Finland. The incidence of CNF based on the results of the present study, ie., 1 in 8200 births, is higher than than that estimated by Norio (1966) . The awareness of Finnish physicians of this disease has certainly improved during the last 10 years. Nevertheless, though the clinical An uncommonly large placenta is the most prominent sign of CNF at birth and has been emphasized in earlier studies (Kouvalainen, Hjelt, and Hallman, 1962; Hallman et al., 1970; Hallman et al., 1973 there is good evidence that in both proteinuria (Seppala and Ruoslahti, 1972) and severe hypoproteinaemia (Kouvalainen, 1963) birth. No good explanation can be given for the abnormally high frequency of breech presentation, but it is supposed that the large placenta interferes with normal intrauterine movements of the fetus (Hallman et al., 1970) .
Pre-and postnatal asphyxia, probably caused by defective function of the oedematous placenta, is a frequent finding in CNF. Asphyxia and prematurity are the most frequent causes for admission to paediatric wards immediately after birth; symptoms of the nephrotic syndrome are the main reasons for admission after the postnatal period. Either oedema or abdominal distension brought on by ascites or by meteoristic bowel were already present in one-quarter of the patients at birth, and in no patient was the full nephrotic syndrome noted later than the age of 2 months. By a few months of age the oedema often disappears and the children then tend to be dystrophic, though the abdominal distension usually persists (Hallman et al., 1970) .
Length of survival of CNF patients has remained practically unchanged since 1965 (Hallman et al., 1970) . In the present series more than half of the infants had died by 6 months and none reached the age of 21 years. Nearly 19% of the necropsies on CNF patients showed either a venous or arterial thrombosis. A tendency towards thrombosis has also been observed in other types of nephrotic syndrome (Levin, Zamit, and Schmaman 1967; Lewy and Wellington, 1974) . The hypothesis that steroid therapy might be an aetiological factor in thrombosis (Lieberman et al., 1968; Mukherjee et al., 1970) receives no support here, because none of the CNF patients with thrombotic complications had been given steroids. Hypovolaemia and an increased incidence of sepsis (Lieberman et al., 1968) together with disturbances in coagulation (Lange et al., 1974) or in fibrinolysis (Scheinman and Stiehm, 1971) are probably the factors which predispose patients to the formation of intravascular thrombi, in both CNF and other types of nephrotic syndrome.
Infections or other definitive causes of death could be documented in about one-half of the CNF patients, whereas in the remainder only CNF could be shown. Though a slight rise of BUN or serum creatinine levels was noted in 14 cases, in none of these could a frank uraemic syndrome be considered as the immediate cause of death. 
